Translating tolerogenic therapies to the clinic - where do we stand?
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early...
Κύριοι συγγραφείς: | Issa, F, Wood, K |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?
ανά: Cobbold, S, κ.ά.
Έκδοση: (2012) -
Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
ανά: Stephen Paul Cobbold, κ.ά.
Έκδοση: (2012-10-01) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
ανά: Eros Marín, κ.ά.
Έκδοση: (2018-02-01) -
Clinical Microbiology: where do we stand?
ανά: Alkiviadis Vatopoulos
Έκδοση: (2024-06-01) -
Gene therapy for clinical transplantation: where do we stand in 2006?
ανά: Tan, P, κ.ά.
Έκδοση: (2006)